For more, read Campath (alemtuzumab) and MS Patients - Positive Phase 2 Results at Health Central.
Friday, October 24, 2008
Most Promising New MS Treatment Found in Campath?
As researchers continue to investigate more effective and safe treatments, we MS patients will continue to read positive reports of clinical trial results and continue to hope for better treatments and possibly a cure someday. This week was one of those weeks. Positive results from a Phase IIb trial comparing alemtuzumab (Campath-1H) with interferon beta-1a (Rebif) was announced by Genzyme Corporation and Bayer HealthCare Pharmaceuticals.